Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.40 |
| ▸ | GNPAT | O15228 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.34 |
| ▸ | NPY4R | P50391 | 3/20 | 0.34 |
| ▸ | NPY1R | P25929 | 2/20 | 0.34 |
| ▸ | NPY2R | P49146 | 2/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12971304 | 0.88 | C3AR1 (0.43) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL29005731 | 0.88 | C3AR1 (0.43) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL27864032 | 0.87 | C3AR1 (0.42) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL21095440 | 0.87 | C3AR1 (0.42) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL1765039 | 0.87 | C3AR1 (0.45) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL1765043 | 0.87 | C3AR1 (0.45) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL5490001 | 0.87 | C3AR1 (0.45) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| Guanidine SCHEMBL28238974 | 0.85 | C3AR1 (0.41) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL7196910 | 0.85 | GNPAT (0.46) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 | |
| SCHEMBL408774 | 0.85 | GNPAT (0.46) | C3AR1GNPATFOLH1SMN1; SMN2NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6329498-B1 | AMINO ACID SEQUENCE; STABLE PREPARATION FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | SEIKAGAKU CORPORATION (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-1016672-A1 | POLYPEPTIDE TRANSITION METAL SALTS AND METHOD OF ENHANCING ANTI-HIV ACTIVITY OF POLYPEPTIDE | SEIKAGAKU CORPORATION (JP) | 2000-07-05 | — | — | EP | disclosed |
| CN-1233257-A | Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide | SEIKAGAKU KOGYO CO LTD (JP) | 1999-10-27 | — | — | CN | disclosed |
| EP-0677061-B1 | POLYPEPTIDES AND ANTI-HIV AGENTS PREPARED THEREFROM | SEIKAGAKU KOGYO CO LTD (JP) | 1999-03-03 | — | — | EP | disclosed |
| US-5776899-A | Polypeptide and anti-HIV agent prepared therefrom | SEIKAGAKU CORPORATION (JP) | 1998-07-07 | — | — | US | disclosed |
| CN-1038841-C | Polypeptide and anti-hiv agent prepared therefrom | SEIKAGAKU CO (JP) | 1998-06-24 | — | — | CN | disclosed |
| CN-1116427-A | Novel polypeptide and anti-HIV agent prepared from the same | SEIKAGAKU KOGYO CO LTD (JP) | 1996-02-07 | — | — | CN | disclosed |
| EP-0677061-A1 | POLYPEPTIDE AND ANTI-HIV AGENT PREPARED THEREFROM | SEIKAGAKU CORPORATION (JP) | 1995-10-18 | — | — | EP | disclosed |
| WO-1995010534-A1 | POLYPEPTIDE AND ANTI-HIV AGENT PREPARED THEREFROM | SEIKAGAKU CORPORATION (JP) | 1995-04-20 | — | — | WO | disclosed |